These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32409382)

  • 1. A review of 117 cases of unprovoked pulmonary embolism and further investigation in patients over 40.
    Angwin C; Rochester A; Jawad M
    Clin Med (Lond); 2020 Mar; 20(Suppl 2):s64. PubMed ID: 32409382
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: A Post-hoc Analysis of the PADIS-PE trial.
    Raj L; Presles E; Le Mao R; Robin P; Sanchez O; Pernod G; Bertoletti L; Jego P; Lemarié CA; Leven F; Hoffmann C; Planquette B; Le Roux PY; Slaun PY; Nonent M; Girard P; Lacut K; Mélac S; Guégan M; Mismetti P; Laporte S; Meyer G; Leroyer C; Tromeur C; Couturaud F;
    Am J Med; 2020 Aug; 133(8):e406-e421. PubMed ID: 32333853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unprovoked Venous Thromboembolism: The Search for the Cause.
    Mwansa H; Zghouzi M; Barnes GD
    Med Clin North Am; 2023 Sep; 107(5):861-882. PubMed ID: 37541713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study.
    Wan T; Rodger M; Zeng W; Robin P; Righini M; Kovacs MJ; Tan M; Carrier M; Kahn SR; Wells PS; Anderson DR; Chagnon I; Solymoss S; Crowther M; White RH; Vickars L; Bazarjani S; Le Gal G
    Thromb Res; 2018 Feb; 162():104-109. PubMed ID: 29224973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual pulmonary vascular obstruction as predictor of pulmonary embolism recurrence after a first unprovoked episode.
    Karathanos C; Spanos K; Giannoukas A
    Thromb Res; 2018 Feb; 162():77-78. PubMed ID: 29310056
    [No Abstract]   [Full Text] [Related]  

  • 6. The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry.
    Prandoni P; Bilora F; Mahé I; Varona JF; Pedrajas JM; Meireles J; Pesavento R; Monreal M;
    Thromb Res; 2023 Apr; 224():17-20. PubMed ID: 36801650
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary embolism: update on management and controversies.
    Duffett L; Castellucci LA; Forgie MA
    BMJ; 2020 Aug; 370():m2177. PubMed ID: 32759284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial.
    Tromeur C; Sanchez O; Presles E; Pernod G; Bertoletti L; Jego P; Duhamel E; Provost K; Parent F; Robin P; Deloire L; Leven F; Mingant F; Bressollette L; Le Roux PY; Salaun PY; Nonent M; Pan-Petesch B; Planquette B; Girard P; Lacut K; Melac S; Mismetti P; Laporte S; Meyer G; Mottier D; Leroyer C; Couturaud F;
    Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29301920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism: results from the REVERSE study.
    Caiano L; Sharkey R; Rodger MA; Kovacs MJ; Le Gal G; Delluc A
    Eur Respir J; 2022 Feb; 59(2):. PubMed ID: 34795036
    [No Abstract]   [Full Text] [Related]  

  • 10. [Risk of recurrence and duration of anticoagulant treatment after deep venous thromboembolism and pulmonary embolism].
    Comuth W; Münster AB; Kümler T; Hellfritzsch M; Larsen SB; Hansen ML; Grove EL
    Ugeskr Laeger; 2019 Feb; 181(7):. PubMed ID: 30777593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of recurrent venous thromboembolism and chronic thromboembolic pulmonary hypertension following a first episode of pulmonary embolism.
    Poli D; Miniati M
    Curr Opin Pulm Med; 2011 Sep; 17(5):392-7. PubMed ID: 21743331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
    Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
    J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary embolism risk stratification by European Society of Cardiology is associated with recurrent venous thromboembolism: Findings from a long-term follow-up study.
    Zhang S; Zhai Z; Yang Y; Zhu J; Kuang T; Xie W; Yang S; Liu F; Gong J; Shen YH; Wang C
    Int J Cardiol; 2016 Jan; 202():275-81. PubMed ID: 26408837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
    Khan F; Tritschler T; Kimpton M; Wells PS; Kearon C; Weitz JI; Büller HR; Raskob GE; Ageno W; Couturaud F; Prandoni P; Palareti G; Legnani C; Kyrle PA; Eichinger S; Eischer L; Becattini C; Agnelli G; Vedovati MC; Geersing GJ; Takada T; Cosmi B; Aujesky D; Marconi L; Palla A; Siragusa S; Bradbury CA; Parpia S; Mallick R; Lensing AWA; Gebel M; Grosso MA; Shi M; Thavorn K; Hutton B; Le Gal G; Rodger M; Fergusson D
    J Thromb Haemost; 2021 Nov; 19(11):2801-2813. PubMed ID: 34379859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism.
    Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; LE Gal G; Solymoss S; Crowther M; Perrier A; Ramsay T; Betancourt MT; White RH; Vickars L; Rodger MA
    J Thromb Haemost; 2010 Sep; 8(9):1926-32. PubMed ID: 20561184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated.
    Kearon C
    J Thromb Thrombolysis; 2011 Apr; 31(3):295-300. PubMed ID: 21331558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticoagulation after an acute pulmonary embolism].
    Le Mao R; Tromeur C; Couturaud F
    Presse Med; 2017; 46(7-8 Pt 1):728-738. PubMed ID: 28756076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-specific differences in the presenting location of a first venous thromboembolism.
    Scheres LJJ; Brekelmans MPA; Beenen LFM; Büller HR; Cannegieter SC; Middeldorp S
    J Thromb Haemost; 2017 Jul; 15(7):1344-1350. PubMed ID: 28440013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis.
    Becattini C; Giustozzi M; Cerdà P; Cimini LA; Riera-Mestre A; Agnelli G
    J Thromb Haemost; 2019 Aug; 17(8):1217-1228. PubMed ID: 31063646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
    Brekelmans MP; Ageno W; Beenen LF; Brenner B; Buller HR; Chen CZ; Cohen AT; Grosso MA; Meyer G; Raskob G; Segers A; Vanassche T; Verhamme P; Wells PS; Zhang G; Weitz JI
    Lancet Haematol; 2016 Sep; 3(9):e437-45. PubMed ID: 27570090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.